Short Interest in Terumo Corp. (OTCMKTS:TRUMY) Expands By 80.3%

Terumo Corp. (OTCMKTS:TRUMY) saw a significant growth in short interest in July. As of July 15th, there was short interest totaling 85,412 shares, a growth of 80.3% from the June 30th total of 47,370 shares. Based on an average daily volume of 287,234 shares, the short-interest ratio is presently 0.3 days. Approximately 0.0% of the shares of the stock are sold short.

Terumo Trading Down 2.7%

Shares of TRUMY stock opened at $14.46 on Friday. The company has a market capitalization of $21.32 billion, a price-to-earnings ratio of 23.70 and a beta of 0.68. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. The firm has a 50-day moving average price of $14.02 and a 200 day moving average price of $13.53. Terumo has a twelve month low of $12.08 and a twelve month high of $19.60.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, May 15th. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11. The company had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. Research analysts forecast that Terumo will post 0.7 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Terumo to a “hold” rating in a research note on Thursday, April 9th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.